Most Recent Articles by Larry Dobrow
"In Australia, we are the healthcare industry," he says.
Nobody knows what the future holds for the Affordable Care Act under the Trump administration and an emboldened Republican Congress.
When his mother suffered from ovarian cancer a decade ago, Robert Herjavec found himself frustrated by the quality of care she received.
Otsuka, Astellas, Takeda, and Daiichi Sankyo share a degree of adventurousness and forward-mindedness in the digital realm.
It is also seeking industry input for a new category of honoree, the Top 10 Innovation Catalysts.
More Articles by Larry Dobrow
Most Recent Blog Posts
- Infographic: Can pharma give doctors what they want?
- Five things for pharma marketers to know: Thursday, January 12, 2017
- Day 2 at JP Morgan: Change is coming, but which drugmakers will stay on top?
- Klick Health's Elliot Langerman on the Power of Persuasion
- Physicians group urges metformin rather than new drugs
- Five things for pharma marketers to know: Wednesday, January 18, 2017
- Industry hires and promotions: January 2017
- The FDA targeted DTC, video, unapproved drug promotion in 2016
- Five things for pharma marketers to know: Tuesday, January 17, 2017
- Trump administration raises questions for rare-disease drugmakers